Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIMAG: Epidural Magnesium Sulfate for Post-caesarean Urinary Retention
NCT06442995Phase 4Recruiting
- Sponsor
- CHU de Reims
- Start
- Jan 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of magnesium sulfate in urinary retention, sponsored by CHU de Reims. Started Jan 2025; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
urinary retention
Beyond the preview
Go deeper on NCT06442995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06442995.